Welcome to the official website of BioCoreUSA Corp!
  • Cores:
    80
    CASES:
    40
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    10
    Tissue Array Type:
    FFPE
    Species:
    Human
FUR803
$255.00
Add To Collect

Description: Uterus cancer with endometrium tissue array, including pathology grade, TNM and clinical satge, 40 cases/80 cores

Details: Endometrioid adenocarcinoma with endometrium tissue microarray, containing 27 cases of endometrioid adenocarcinoma, 1 each of mucinous adenocarcinoma, squamous cell carcinoma and clear cell adenocarcinoma, 5 each of adjacent endometrium tissue and endometrium tissue, duplicate cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • NAT(*)
  • Normal(*)
  • Malignant(I)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IC)
  • Malignant(II)
  • Malignant(IIIC)
  • _ma
TISSUE ARRAYS
FUR803
1
2
3
4
5
6
7
8
9
10
A
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
B
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
C
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
D
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
E
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
F
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
G
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
H
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
_ma
FUR803
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 44 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
A2
2 44 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant
A3
3 62 F Uterus Endometrioid adenocarcinoma 1 T1b1N1M0 IIIC Malignant
A4
4 62 F Uterus Endometrioid adenocarcinoma 1 T1b1N1M0 IIIC Malignant
A5
5 61 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
A6
6 61 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
A7
7 33 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
A8
8 33 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
A9
9 73 F Uterus Endometrioid adenocarcinoma (sparse) 1 T1cN0M0 IC Malignant
A10
10 73 F Uterus Endometrioid adenocarcinoma (sparse) 1 T1cN0M0 IC Malignant
B1
11 61 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
B2
12 61 F Uterus Endometrioid adenocarcinoma 1 T1cN0M0 IC Malignant
B3
13 58 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B4
14 58 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant
B5
15 62 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
B6
16 62 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
B7
17 39 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
B8
18 39 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
B9
19 48 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
B10
20 48 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C1
21 47 F Uterus Endometrioid adenocarcinoma * T1bN0M0 IB Malignant
C2
22 47 F Uterus Endometrioid adenocarcinoma * T1bN0M0 IB Malignant
C3
23 43 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C4
24 43 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C5
25 51 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
C6
26 51 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
C7
27 42 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C8
28 42 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C9
29 62 F Uterus Endometrioid adenocarcinoma 2 T1cN1M0 IIIC Malignant
C10
30 62 F Uterus Endometrioid adenocarcinoma 2 T1cN1M0 IIIC Malignant
D1
31 62 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D2
32 62 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D3
33 56 F Uterus Endometrioid adenocarcinoma * T1N0M0 I Malignant
D4
34 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D5
35 70 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
D6
36 70 F Uterus Endometrioid adenocarcinoma * T1bN0M0 IB Malignant
D7
37 52 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
D8
38 52 F Uterus Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant
D9
39 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
D10
40 56 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
E1
41 42 F Uterus Endometrioid adenocarcinoma * T1bN0M0 IB Malignant
E2
42 42 F Uterus Endometrioid adenocarcinoma * T1bN0M0 IB Malignant
E3
43 61 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
E4
44 61 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
E5
45 46 F Uterus Mucinous adenocarcinoma with necrosis 2--3 T3N2M0 IIIC Malignant
E6
46 46 F Uterus Mucinous adenocarcinoma 2--3 T3N2M0 IIIC Malignant
E7
47 23 F Uterus Endometrioid adenocarcinoma 3 T3N2M0 IIIC Malignant
E8
48 23 F Uterus Endometrioid adenocarcinoma 3 T3N2M0 IIIC Malignant
E9
49 58 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
E10
50 58 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F1
51 77 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F2
52 77 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F3
53 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F4
54 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant
F5
55 48 F Uterus Endometrioid adenocarcinoma with squamous metaplasia 3 T2N0M0 II Malignant
F6
56 48 F Uterus Endometrioid adenocarcinoma with squamous metaplasia 3 T2N0M0 II Malignant
F7
57 53 F Uterus Squamous cell carcinoma 3 T1N0M0 I Malignant
F8
58 53 F Uterus Squamous cell carcinoma 3 T1N0M0 I Malignant
F9
59 63 F Uterus Clear cell adenocarcinoma * T3cN1M0 IIIC Malignant
F10
60 63 F Uterus Clear cell adenocarcinoma (sparse) * T3cN1M0 IIIC Malignant
G1
61 49 F Uterus Adjacent normal endometrium tissue (sparse) * * * NAT
G2
62 49 F Uterus Adjacent normal endometrium tissue * * * NAT
G3
63 67 F Uterus Adjacent normal endometrium tissue * * * NAT
G4
64 67 F Uterus Adjacent normal endometrium tissue * * * NAT
G5
65 52 F Uterus Adjacent normal endometrium tissue * * * NAT
G6
66 52 F Uterus Adjacent normal endometrium tissue * * * NAT
G7
67 48 F Uterus Adjacent normal endometrium tissue * * * NAT
G8
68 48 F Uterus Adjacent normal endometrium tissue (sparse) * * * NAT
G9
69 56 F Uterus Adjacent normal endometrium tissue * * * NAT
G10
70 56 F Uterus Adjacent normal endometrium tissue * * * NAT
H1
71 21 F Uterus Endometrium tissue * * * Normal
H2
72 21 F Uterus Endometrium tissue * * * Normal
H3
73 40 F Uterus Endometrium tissue * * * Normal
H4
74 40 F Uterus Endometrium tissue * * * Normal
H5
75 15 F Uterus Endometrium tissue * * * Normal
H6
76 15 F Uterus Endometrium tissue * * * Normal
H7
77 21 F Uterus Endometrium tissue * * * Normal
H8
78 21 F Uterus Endometrium tissue * * * Normal
H9
79 18 F Uterus Endometrium tissue * * * Normal
H10
80 18 F Uterus Endometrium tissue * * * Normal
_malignant_melanoma_
Find overlapping cases with this tissue array:
  • FUR803
    File Format: .xlsx
    Release Date: 2025-01-17 16:01:03
    Download
0.581154s